- Home
- / Neurogastrx
Neurogastrx
Total Funding
$45 M
Neurogastrx Summary
Company Summary
- Overview
- Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment. Its lead product is under development for the treatment of gastroparesis, a debilitating condition caused by abnormal gastric function.
- Type
- Private
- Status
- Active
- Founded
- 2012
- HQ
- Woburn, MA, US | view all locations
- Website
- http://www.neurogastrx.com/
- Cybersecurity rating
Table of Contents
Key People
Jim O'Mara, President, Chief Executive Officer & Director
David Allison, Director
Kevin Koch, Director
LocationsView all
1 location detected
Woburn, MA HQ
United States
60 Unicorn Park Dr